CervoMed announced its expected addition to the Russell 2000 and Russell 3000 Indexes at the conclusion of the 2024 Russell U.S. Indexes annual reconstitution, effective when the U.S. equity markets open on Monday, July 1, 2024, according to the final preliminary list of 2024 additions posted on the FTSE Russell website on June 21st 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRVO:
- CervoMed announces completion of enrollment in Phase 2b RewinD-LB trial
- CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
- CervoMed initiated with a Buy at JonesResearch
- CervoMed appoints Elder as Chief Financial Officer
- CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates